Interleukin6

Roles of IL-6-gp130 Signaling in Vascular Inflammation.
[19936194] Curr Cardiol Rev 4(3): 179-92 (2008)

Directing transition from innate to acquired immunity: defining a role for IL-6.
[16148087] J Immunol 175(6): 3463-8 (2005)

Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer.
[16707558] J Leukoc Biol 80(2): 227-36 (2006)

Interleukin-6 trans-signalling in chronic inflammation and cancer.
[16640655] Scand J Immunol 63(5): 321-9 (2006)

Interleukin-6 biology is coordinated by membrane bound and soluble receptors.
[14515143] Acta Biochim Pol 50(3): 603-11 (2003)

Interleukin-6 in the injured patient. Marker of injury or mediator of inflammation?
[8916880] Ann Surg 224(5): 647-64 (1996)

Decomposition of diverse litter mixtures in streams.
[17489470] Ecology 88(1): 219-27 (2007)

Targeted anti-interleukin-6 monoclonal antibody therapy for cancer: a review of the rationale and clinical evidence.
[14581334] Clin Cancer Res 9(13): 4653-65 (2003)

The biology of interleukin-6.
[2473791] Blood 74(1): 1-10 (1989)

Therapeutic targets in rheumatoid arthritis: the interleukin-6 receptor.
[19854855] Rheumatology (Oxford) 49(1): 15-24 (2010)

Interleukin-6 and rheumatic diseases.
[16899108] Arthritis Res Ther 8 Suppl 2(-): S4 (2006)

The soluble interleukin 6 receptor takes its place in the pantheon of interleukin 6 signaling proteins: phenoconversion of cardiac fibroblasts to myofibroblasts.
[20606105] Hypertension 56(2): 193-5 (2010)

The nuclear factor-kappaB-interleukin-6 signalling pathway mediating vascular inflammation.
[20202975] Cardiovasc Res 86(2): 211-8 (2010)

Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling.
[21881215] J Clin Invest 121(9): 3375-83 (2011)

Muscle as an endocrine organ: focus on muscle-derived interleukin-6.
[18923185] Physiol Rev 88(4): 1379-406 (2008)

Muscle-derived interleukin-6: mechanisms for activation and possible biological roles.
[12205025] FASEB J 16(11): 1335-47 (2002)

Interleukin-6 and its receptor in cancer: implications for translational therapeutics.
[17849470] Cancer 110(9): 1911-28 (2007)

Principles of interleukin (IL)-6-type cytokine signalling and its regulation.
[12773095] Biochem J 374(Pt 1): 1-20 (2003)

Blocking the IL-6-STAT3 signaling pathway: potential liver cancer therapy.
[21345134] Future Oncol 7(2): 161-4 (2011)

Interleukin 6 in autoimmune and inflammatory diseases: a personal memoir.
[20689230] Proc Jpn Acad Ser B Phys Biol Sci 86(7): 717-30 (2010)

IL-6 and extracellular matrix remodeling.
[16266225] Rev Esp Enferm Dig 97(8): 575-95 (2005)

The protein product of the tumor suppressor gene, melanoma differentiation-associated gene 7, exhibits immunostimulatory activity and is designated IL-24.
[12055212] J Immunol 168(12): 6041-6 (2002)

Intratumoral injection of INGN 241, a nonreplicating adenovector expressing the melanoma-differentiation associated gene-7 (mda-7/IL24): biologic outcome in advanced cancer patients.
[15585417] Mol Ther 11(1): 160-72 (2005)

C/EBP homologous protein deficiency attenuates myocardial reperfusion injury by inhibiting myocardial apoptosis and inflammation.
[21330607] Arterioscler Thromb Vasc Biol 31(5): 1124-32 (2011)

Structure-activity analysis of diffusible lipid electrophiles associated with phospholipid peroxidation: 4-hydroxynonenal and 4-oxononenal analogues.
[21291287] Chem Res Toxicol 24(3): 357-70 (2011)

Interleukin-6 inhibition for treatment of rheumatoid arthritis: a review of tocilizumab therapy.
[21116333] Drug Des Devel Ther 4(-): 263-78 (2010)

Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies.
[21625400] Cancer Manag Res 3(-): 177-89 (2011)

Interleukin-6 in bone metastasis and cancer progression.
[20335016] Eur J Cancer 46(7): 1223-31 (2010)

Rationale for interleukin-6 blockade in systemic lupus erythematosus.
[15230289] Lupus 13(5): 339-43 (2004)

Hyponatremia and inflammation: the emerging role of interleukin-6 in osmoregulation.
[21196778] Nephron Physiol 118(2): 45-51 (2011)

Interleukin-6 and cardiovascular diseases.
[15090695] Jpn Heart J 45(2): 183-93 (2004)

Essential role of IL-6 signaling pathway in keloid pathogenesis.
[17384473] J Nihon Med Sch 74(1): 11-22 (2007)

n-3 polyunsaturated fatty acids and autoimmune-mediated glomerulonephritis.
[20189790] Prostaglandins Leukot Essent Fatty Acids 82(4-6): 251-8 (2010)

gp130 at the nexus of inflammation, autoimmunity, and cancer.
[20610800] J Leukoc Biol 88(6): 1145-56 (2010)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Fatal error: Uncaught Error: Call to undefined function mysql_connect() in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Interleukin6.php:92 Stack trace: #0 {main} thrown in C:\Inetpub\vhosts\kidney.de\httpdocs\bdom\Interleukin6.php on line 92